Chairman of the Board and Chief Executive Officer
As Chairman and CEO of PAREXEL, which he founded in 1982, Mr. von Rickenbach has taken PAREXEL from its pioneering beginnings as one of the first clinical research organizations (CROs) more than two decades ago to its place as one of the top three public clinical service providers today. He has led PAREXEL through its IPO, multiple public offerings, and over 30 acquisitions during the Company’s history of more than 25 years to expand its portfolio in order to meet changing client needs and market demand. Under his leadership, PAREXEL has evolved to provide a broad range of services to the biopharmaceutical industry, including integrated clinical development, regulatory affairs consulting, commercialization services and technologies that expedite time-to-market.

Josef H. von Rickenbach
Chairman of the Board
and Chief Executive Officer


